http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4387092-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b3db7dd56b56cc6d94d0e0cccc38322
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755
filingDate 1980-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1983-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_155b1dc44037fb1c909b2a51dd80c0b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b2d245c69606906763420898dd6fb33
publicationDate 1983-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4387092-A
titleOfInvention Process for the preparation of factor VIII concentrate
abstract An improved process for preparing factor VIII concentrate which comprises a first stage wherein fibrinogen is precipitated from a buffered plasma or plasma cryoprecipitate solution by the addition of a polyol and a second stage where factor VIII is precipitated from the resulting supernatant also by the addition of a polyol. The improvement in the first stage resides in adding the polyol in an amount of 1-3% and maintaining the temperature of the buffered solution between about 2°-4° C.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5668108-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8765665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9352027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5633150-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5654147-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4743680-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010168018-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5618789-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8058226-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7087723-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004116345-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5618788-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4847362-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4543210-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372800-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5824780-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6586573-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5576291-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8753406-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9669076-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4739039-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4650858-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5683905-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006205661-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008306610-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020459-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7247707-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4952675-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10512674-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022099223-A2
priorityDate 1979-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4085095-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3631018-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3770631-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4069216-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226771973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18414901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18504422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128131686

Total number of triples: 54.